Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
Shopping Cart Icon(0 items)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Related Markets
Biotechnology
Research & Development
Antisense & RNAi Technology

Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

Optimizing Synthetic RNAi: Perspectives from the Pharmaceutical and Biotech Industry

BioInformatics, LLC
December 1, 2006
115 Pages - Pub ID: BIF1492282
 
Questions about this report >
Order by fax >
XE.com
Abstract

 Table of
Contents		 Related Reports

The price of this report has been reduced due to its age.
This report identifies the RNAi research objectives of pharmaceutical and biotech scientists and present siRNA customer purchasing preferences by key experimental design parameters

Related Reports:
Sanofi-Aventis SA (SNY) Profile & Biotech Industry Trends Analysis 2010
Biotechnology Sector
Monoclonal antibodies: 2009 update
Opportunities in Human Embryonic Stem Cell (hESC) Products
Global Stem Cell and Advanced Technologies Market
Stem Cell Therapies: Commercial R & D Mega Pipeline Report
United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis
China Pharma Outsourcing Annual Review 2009
Scientific Research in Australia - Industry Risk Rating Report
Biotechnology in Australia - Industry Risk Rating Report
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/25/2009 - 4